z-logo
open-access-imgOpen Access
Interstitial Viable Ectopic Pregnancy Managed with Systemic Methotrexate
Author(s) -
Ibrahim Hegazy
Publication year - 2022
Language(s) - English
DOI - 10.47363/jgrrr/2022(4)148
Subject(s) - ectopic pregnancy , medicine , methotrexate , miscarriage , obstetrics , human chorionic gonadotropin , vaginal bleeding , pregnancy , salpingostomy , medical history , products of conception , gynecology , abortion , surgery , hormone , genetics , biology
A 29-year-old woman, 6weeks and 3 days pregnant as assessed by her last menstrual period, presented to our emergency department with vaginal bleeding and pelvic pain for 4 days. She was a gravida 3 para 0 with a history of ectopic on her first pregnancy in the left tube managed by salpingostomy, her second pregnancy was unfortunately a miscarriage at 7 wks managed by medical management and ERPC. At the time of diagnosis, she had a left interstitial ectopic pregnancy with serum B human chorionic gonadotropin (β-HCG) was 20094 mIU / mL. The ectopic pregnancy was managed by intramuscular methotrexate.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here